<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-34016" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Polymorphic Light Eruption</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Oakley</surname>
            <given-names>Amanda M.</given-names>
          </name>
          <aff>University of Auckland</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramsey</surname>
            <given-names>Michael L.</given-names>
          </name>
          <aff>Geisinger Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amanda Oakley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Ramsey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-34016.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Polymorphic light eruption is the most common form of immunologically mediated photosensitivity dermatoses. Exposure to sunlight in spring or summer results in an irritable rash that resolves within a few days, providing further exposure is avoided. This activity reviews the pathophysiology of polymorphic light eruption and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of polymorphic light eruption.</p></list-item><list-item><p>Review the presentation of polymorphic light eruption.</p></list-item><list-item><p>Outline the treatment and management options available for polymorphic light eruption.</p></list-item><list-item><p>Summarize the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by polymorphic light eruption.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=34016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=34016">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-34016.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Polymorphic light eruption is the most common form of immunologically mediated photosensitivity dermatoses. Exposure to sunlight in spring or summer results in an irritable rash that resolves within a few days, providing further exposure is avoided. Variants include juvenile spring eruption (vesicles on the ears of young boys) and PMLE sine eruption (pruritus on sun-exposed skin without visible skin changes). Polymorphic light eruption is also known as polymorphous light eruption and prurigo aestivalis.</p>
      </sec>
      <sec id="article-34016.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p> The cause of polymorphic light eruption is unknown. It is postulated that there is a delayed hypersensitivity reaction to an endogenous antigen expressed after exposure to sunlight or artificial sources of ultraviolet (UV) radiation. Theories must account for increased prevalence in women and for the hardening effect of on-going exposure to ultraviolet radiation.&#x000a0;<xref ref-type="bibr" rid="article-34016.r1">[1]</xref></p>
      </sec>
      <sec id="article-34016.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of polymorphic light eruption varies worldwide. Affected individuals may experience it every time they go outdoors, or only occasionally. It is more common in Northern Europe (15% in the UK) than in Australasia (5%). It affects all skin types but is more common in lighter skin especially Fitzpatrick skin phototype 1, than in darker skins. It most often (about 75% of cases) begins in females aged 20 to 40 years but may start in childhood or later in life.&#x000a0;More people experience polymorphic light eruption at high altitude than at sea level.<xref ref-type="bibr" rid="article-34016.r1">[1]</xref></p>
      </sec>
      <sec id="article-34016.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Twin studies indicate a polygenic model may explain familial clustering. Sunburn reaction in patients affected by polymorphous light eruption is normal.</p>
        <p>Current theories involve two steps that lead to a polymorphous light eruption. An unknown photoantigen is rendered immunogenic on exposure to UV. This does not cause a problem in unaffected individuals because of UV-induced suppression. In patients with a polymorphic light eruption, T&#x02013;cell function is not suppressed by UV radiation until photo-hardening has taken place. The putative antigen induced by UV radiation leads to a predominance of CD4+ T cells and the production of proinflammatory cytokines such as interleukin (IL) 1. Vitamin D insufficiency, the role of estrogen in preventing UV-induced immune suppression, and dysregulated antimicrobial factors may be relevant.</p>
        <p>The hardening effect, where further exposure to UV prevents the eruption, is not fully understood&#x000a0;and could involve tanning, hyperkeratosis, and acanthosis of the epidermis, and/or the development of immunological tolerance.&#x000a0;<xref ref-type="bibr" rid="article-34016.r1">[1]</xref><xref ref-type="bibr" rid="article-34016.r2">[2]</xref></p>
      </sec>
      <sec id="article-34016.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p> UV-A is the&#x000a0;usual&#x000a0;part of the electromagnetic spectrum that provokes polymorphous light eruption (75% to 90%). However, it can be triggered in some patients by UV-B or visible light.&#x000a0;Exposure may be to sunlight or to an artificial or medical source of ultraviolet radiation.<xref ref-type="bibr" rid="article-34016.r3">[3]</xref></p>
      </sec>
      <sec id="article-34016.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The first sign of polymorphous light eruption typically appears after first exposure to intense sunlight during the spring or early summer in temperate climates. Several hours to days later, an irritable&#x000a0;rash appears on areas newly exposed to the light such as the d&#x000e9;colletage, forearms, backs of hands, lower legs and feet. It rarely affects the face. It also occurs in some patients treated for inflammatory skin diseases with phototherapy, when it may appear on the trunk and proximal limbs.</p>
        <p>The most common morphology is smooth-topped erythematous papules, which can coalesce into plaques.&#x000a0;Morphology varies&#x000a0;between&#x000a0;individuals&#x000a0;and can include macules, vesicles, lichenoid plaques, prurigo papules and targetoid lesions resembling erythema multiforme.</p>
        <p>Rarely, systemic features such as fever, malaise, and headaches, have been associated with the eruption.</p>
        <p>The rash persists for several days then clears up without scarring if further exposure to UV is avoided. It may persist for weeks or months if repeatedly exposed, although in most individuals gradual exposure leads to hardening so that the eruption does not occur in late summer.</p>
        <p>Polymorphic light eruption tends to recur annually&#x000a0;and is some&#x000a0;patients persists throughout the year, depending on latitude. It often reduces in severity over time and eventually resolves with a lower prevalence in older people.&#x000a0;<xref ref-type="bibr" rid="article-34016.r1">[1]</xref></p>
      </sec>
      <sec id="article-34016.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Skin biopsy shows upper dermal edema, and a dense perivascular and periadnexal lymphocytic infiltrate without vasculitis. Plasmacytoid dendritic cells and T regulatory cells predominate.&#x000a0;<xref ref-type="bibr" rid="article-34016.r4">[4]</xref>&#x000a0;Neutrophils may be seen in early lesions. Spongiosis, vesicle formation, and liquefaction degeneration may be seen dependent on the clinical signs. Direct immunofluorescence testing is negative.</p>
        <p>In most patients with a polymorphic light eruption, blood tests will&#x000a0;reveal normal results. However, positive antinuclear antibody and extractable nuclear antigen (anti-Ro/La) in low titer may be detected, even in the absence of other criteria to suggest a diagnosis of lupus erythematosus.&#x000a0;&#x000a0;When the history or clinical findings indicate, urinary and red cell porphyrin screening may be performed and are negative.</p>
        <p>Phototesting is rarely necessary. Specialized centers may undertake photoprovocation testing in late winter, to determine inciting wavelengths. This involves exposure of 5-cm squares of usually-affected skin to 1&#x02013;2 minimal erythema doses (MED) of broadband UVB and to varying doses of UVA.&#x000a0; The test is repeated on the same site daily for 3 days and the area examined to detect the typical rash. False negative responses occur in 10% to 40% of tested individuals. Formal monochromator MED testing is non-contributory, usually demonstrating expected results for the patient&#x02019;s skin color.&#x000a0;<xref ref-type="bibr" rid="article-34016.r5">[5]</xref></p>
      </sec>
      <sec id="article-34016.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management requires determining what provokes the eruption and then attempting to minimize this, while at the same time&#x000a0;gradually increasing exposure to induce hardening.</p>
        <p>Explain that UV-A is a large component of sunlight and can cause the light eruption without sunburn (as sunburn is mainly due to UV-B). UV-A, unlike UV-B, can penetrate window glass&#x000a0;and is less well blocked by sunscreens. When in situations that are likely to provoke the rash, cover up as much as possible with densely woven clothing. Select broad-spectrum, water-resistant semi-opaque sun protection factor (SPF) 50+ sunscreens and apply before exposure and every two hours on skin that is not covered.</p>
        <p>Low-dose narrowband UV-B and other forms of phototherapy undertaken in late winter or early skin can reduce the incidence and severity of polymorphous light eruption. The course is 2 to 3 treatments per week for 4 to 6 weeks each year.&#x000a0;<xref ref-type="bibr" rid="article-34016.r6">[6]</xref></p>
        <p>There is some&#x000a0;evidence to support prophylactic short courses of oral steroids (for example, to prevent the eruption during a holiday break), hydroxychloroquine, and antioxidants such as Polypodium leucotomes extract, lycopene, beta-carotene, nicotinamide and astaxanthin.&#x000a0;</p>
        <p>The eruption is treated with topical corticosteroids with some benefit in reducing symptoms and duration.<xref ref-type="bibr" rid="article-34016.r2">[2]</xref></p>
      </sec>
      <sec id="article-34016.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The main differential diagnosis is photosensitivity associated with lupus erythematosus, which may behave and appear similar but tends to be more persistent. Solar urticaria occurs during or shortly after exposure and resolves within an hour or so&#x000a0;of covering up. Photosensitivity dermatitis is more persistent with eczematous morphology.<xref ref-type="bibr" rid="article-34016.r5">[5]</xref></p>
      </sec>
      <sec id="article-34016.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Polymorphous light eruption is generally&#x000a0;uncomplicated but severe disease can lead to emotional distress, anxiety and depression.&#x000a0;</p>
      </sec>
      <sec id="article-34016.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PLE is a relatively common skin disorder that is not easy to diagnose or manage. The disorder may be confused with many other skin disorders and thus is best managed by a dermatologist. However, once the diagnosis is made, the patient may be monitored by the primary care physician and nurse practitioner. These healthcare professionals should educate the patients on preventio which includes wearing appropriate garments when going outside and use ample sunscreen frequently.</p>
        <p>The condition is benign but recurrences are common leading to emotional distress and isolation. Thus, a patient may benefit from a mental health counsultant.<xref ref-type="bibr" rid="article-34016.r7">[7]</xref><xref ref-type="bibr" rid="article-34016.r8">[8]</xref>&#x000a0;(Level V)</p>
      </sec>
      <sec id="article-34016.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=34016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=34016">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/polymorphic-light-eruption-sunlight-sensitivity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=34016">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/34016/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=34016">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-34016.s14">
        <fig id="article-34016.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Polymorphic light eruption <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pmle2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-34016.s15">
        <fig id="article-34016.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Papular polymorphic light eruption on lower legs in female <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="polymorphic-light-eruption-013" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-34016.s16">
        <title>References</title>
        <ref id="article-34016.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gruber-Wackernagel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Polymorphous light eruption: clinic aspects and pathogenesis.</article-title>
            <source>Dermatol Clin</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-34, viii</page-range>
            <pub-id pub-id-type="pmid">24891054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lembo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Raimondo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Polymorphic Light Eruption: What's New in Pathogenesis and Management.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>252</fpage>
            <pub-id pub-id-type="pmid">30250845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gruber-Wackernagel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hofer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Legat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseases.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-105</page-range>
            <pub-id pub-id-type="pmid">30267642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Arisi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lonardi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lorenzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ungari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Serana</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fusano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moggio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Calzavara-Pinton</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Venturini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous infiltration of plasmacytoid dendritic cells and T regulatory cells in skin lesions of polymorphic light eruption.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>985</fpage>
            <page-range>985-991</page-range>
            <pub-id pub-id-type="pmid">29430717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kannan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of patients with photodermatoses.</article-title>
            <source>Dermatol Clin</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-75, vii</page-range>
            <pub-id pub-id-type="pmid">24891050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Combalia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Sartorio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fust&#x000e0;</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Morgado-Carrasco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Podlipnik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aguilera</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Successful Short Desensitization Treatment Protocol with Narrowband UVB Phototherapy (TL-01) in Polymorphic Light Eruption.</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>108</volume>
            <issue>8</issue>
            <fpage>752</fpage>
            <page-range>752-757</page-range>
            <pub-id pub-id-type="pmid">28549611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizwan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reddick</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bundy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Unsworth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Photodermatoses: environmentally induced conditions with high psychological impact.</article-title>
            <source>Photochem Photobiol Sci</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>182</fpage>
            <page-range>182-9</page-range>
            <pub-id pub-id-type="pmid">22961505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34016.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richards</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Ling</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Evangelou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brooke</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Fortune</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Evidence of high levels of anxiety and depression in polymorphic light eruption and their association with clinical and demographic variables.</article-title>
            <source>Br J Dermatol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>159</volume>
            <issue>2</issue>
            <fpage>439</fpage>
            <page-range>439-44</page-range>
            <pub-id pub-id-type="pmid">18510674</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
